The Desk · Daily since 18:00
What we're reading.
Short editorial takes on clinical AI, longevity, neurotech, digital therapeutics, and the Portuguese & European health-tech ecosystem. Grouped by day; one daily read published every evening at 18:00 Europe/Lisbon. See the daily archive →
144 / 144
ShowHide briefing index
IEEE Spectrum – Biomedical
Adaptyx Bioscience's Continuous Cortisol Wearable: A New Frontier?
"While Adaptyx's technical achievement in continuous cortisol sensing is notable, the clinical utility beyond specific adrenal disorders remains unproven; most 'stress' is subjective and not resolved by a biomarker delta."
Read source →
ShowHide briefing index
BioPharma Dive
Jasper Therapeutics Acquired by Kira Pharmaceuticals, Secures Mirador Licensing Deal
"While the M&A offers a lifeline, the necessity for a concurrent licensing deal with Mirador suggests ongoing R&D challenges or an underperforming pipeline at Jasper, impacting unit economics for the combined entity. This reflects the intense capital demands and inherent risks within niche biopharma."
Read source →
MedCity News
Juno Bio Secures $3.8M for Vaginal Microbiome Diagnostics
"While the funding signifies investor confidence, the real traction for Juno Bio will depend on demonstrating superior clinical utility and clear reimbursement pathways for its diagnostic tools, particularly given existing women's health diagnostic options."
Read source →
MedCity News
GSK’s $2B Chronic Cough Drug, Camlipixant, Fails Phase 3
"This preclinical failure underscores the high attrition rates even for well-funded programs, illustrating that capital deployment does not guarantee clinical efficacy or regulatory approval; the mechanism of action did not translate to desired patient outcomes."
Read source →